InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BGC | That didn't take long for the sp to collapse! Down 68% at one stage. | 02/07/16 | 4 | 2.1K | |||
|
|||||||
BGC | Ann: Change of Name and ASX Code-BGC.AX | 19/05/16 | 0 | 579 | |||
|
|||||||
BGC | Ann: Form 605 - Ceasing to be Substantial Shareholder-BGC.AX | 08:45 | 0 | 398 | |||
|
|||||||
BGC | Ann: Form 603 - Substantial Shareholder Notice-BGC.AX | 08:45 | 0 | 334 | |||
|
|||||||
BGC | Ann: Initial Director's Interest-BGC.AX | 13/05/16 | 0 | 318 | |||
|
|||||||
BGC | Ann: Appendix 3B-BGC.AX | 13/05/16 | 0 | 339 | |||
|
|||||||
BGC | Ann: Acquisition of MEJority Securities - Fair Value Report-BGC.AX | 13/05/16 | 0 | 275 | |||
|
|||||||
BGC | Ann: Acquisition of MEJority Securities - Settlement-BGC.AX | 13/05/16 | 0 | 293 | |||
|
See All Discussions